Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rotman

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 15, 1997
Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology GroupC A Lawton, K Winter, R Byhardt, et al.
Cancer|September 15, 1982
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology GroupC A Perez, K Stanley, G Grundy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservationV Valentini, C Coco, N Cellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413M Roach, M DeSilvio, C Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytomaM D Prados, C B Scott, M Rotman, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studiesV Valentini, C Coco, N Cellini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distributionJ A Carrasquillo, J D White, C H Paik, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1997
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02B Donahue, C B Scott, J S Nelson, et al.
Radiology|October 19, 2000
Bone metastases. American College of Radiology. ACR Appropriateness CriteriaA R Kagan, C M Rose, J M Bedwinek, et al.
American Journal of Clinical Oncology|June 17, 1998
Management of carcinoma of the bladderZ Petrovich, L Baert, S D Boyd, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|July 15, 1997
Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology GroupC A Lawton, K Winter, R Byhardt, et al.
Cancer|September 15, 1982
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology GroupC A Perez, K Stanley, G Grundy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservationV Valentini, C Coco, N Cellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413M Roach, M DeSilvio, C Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytomaM D Prados, C B Scott, M Rotman, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studiesV Valentini, C Coco, N Cellini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 1999
Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distributionJ A Carrasquillo, J D White, C H Paik, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1997
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02B Donahue, C B Scott, J S Nelson, et al.
Radiology|October 19, 2000
Bone metastases. American College of Radiology. ACR Appropriateness CriteriaA R Kagan, C M Rose, J M Bedwinek, et al.
American Journal of Clinical Oncology|June 17, 1998
Management of carcinoma of the bladderZ Petrovich, L Baert, S D Boyd, et al.
Pageof 19